Complement, cold agglutinins, and therapy

被引:16
作者
Berentsen, Sigbjorn [1 ]
机构
[1] Haugesund Hosp, Haugesund, Norway
关键词
ACTIVATION; INHIBITOR; RITUXIMAB; DISEASE;
D O I
10.1182/blood-2014-04-568733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4010 / 4012
页数:5
相关论文
共 10 条
[1]   Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients [J].
Berentsen, S ;
Ulvestad, E ;
Gjertsen, BT ;
Hjorth-Hansen, H ;
Langholm, R ;
Knutsen, H ;
Ghanima, W ;
Shammas, FV ;
Tjonnfjord, GE .
BLOOD, 2004, 103 (08) :2925-2928
[2]  
Berentsen S, 2006, HAEMATOLOGICA, V91, P460
[3]   High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease [J].
Berentsen, Sigbjorn ;
Randen, Ulla ;
Vagan, Anne Marita ;
Hjorth-Hansen, Henrik ;
Vik, Anders ;
Dalgaard, Jakob ;
Jacobsen, Eva-Marie ;
Thoresen, Aud S. ;
Beiske, Klaus ;
Tjonnfjord, Geir E. .
BLOOD, 2010, 116 (17) :3180-3184
[4]   ROLE OF COMPLEMENT IN CLEARANCE OF COLD AGGLUTININ-SENSITIZED ERYTHROCYTES IN MAN [J].
JAFFE, CJ ;
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (04) :942-949
[5]   Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma [J].
Randen, Ulla ;
Troen, Gunhild ;
Tierens, Anne ;
Steen, Chloe ;
Warsame, Abdirashid ;
Beiske, Klaus ;
Tjonnfjord, Geir E. ;
Berentsen, Sigbjorn ;
Delabie, Jan .
HAEMATOLOGICA, 2014, 99 (03) :497-504
[6]   Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria [J].
Risitano, Antonio M. ;
Ricklin, Daniel ;
Huang, Yijun ;
Reis, Edimara S. ;
Chen, Hui ;
Ricci, Patrizia ;
Lin, Zhuoer ;
Pascariello, Caterina ;
Raia, Maddalena ;
Sica, Michela ;
Del Vecchio, Luigi ;
Pane, Fabrizio ;
Lupu, Florea ;
Notaro, Rosario ;
Resuello, Ranillo R. G. ;
DeAngelis, Robert A. ;
Lambris, John D. .
BLOOD, 2014, 123 (13) :2094-2101
[7]   Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease [J].
Roeth, Alexander ;
Huettmann, Andreas ;
Rother, Russell P. ;
Duehrsen, Ulrich ;
Philipp, Thomas .
BLOOD, 2009, 113 (16) :3885-3886
[8]   TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins [J].
Shi, Ju ;
Rose, Eileen L. ;
Singh, Andrew ;
Hussain, Sami ;
Stagliano, Nancy E. ;
Parry, Graham C. ;
Panicker, Sandip .
BLOOD, 2014, 123 (26) :4015-4022
[9]   Cold agglutinin disease [J].
Swiecicki, Paul L. ;
Hegerova, Livia T. ;
Gertz, Morie A. .
BLOOD, 2013, 122 (07) :1114-1121
[10]   Acute phase haemolysis in chronic cold agglutinin disease [J].
Ulvestad, E ;
Berentsen, S ;
Mollnes, TE .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :239-242